查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386334

急性脊髓损伤市场报告：2030 年趋势、预测与竞争分析

Acute Spinal Cord Injury Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

急性脊髓损伤的趋势和预测

预计到 2030 年，全球急性脊髓损伤市场将达到约 96 亿美元，2024 年至 2030 年复合年增长率为 5.6%。该市场的主要驱动因素是人们对早期治疗益处的认识不断提高、急性脊髓损伤患病率上升以及极限运动活动在全球范围内日益普及。全球急性脊髓损伤市场的未来充满希望，医院和创伤中心市场充满机会。

急性脊髓损伤市场洞察

Lucintel 预测，由于脊髓损伤盛行率不断增加以及人们对脊髓损伤治疗的认识不断增强，不完全性脊髓损伤 (ISCI) 在预测期内将继续占据较大份额。

由于医院住院復健计画的增加以及提供帮助人们的综合服务，预计医院将继续占据该市场的很大一部分。

由于人口迅速高龄化、发达的医疗保健系统以及先进技术的采用增加，预计北美仍将是最大的地区。

市场规模/估计：以金额估计急性脊髓损伤的市场规模（十亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

细分市场分析：按类型、最终用途和金额估算急性脊髓损伤市场规模（十亿美元）。

区域分析：北美、欧洲、亚太地区和世界其他地区的急性脊髓损伤市场细分。

成长机会：急性脊髓损伤市场按类型、最终用途和区域进行的成长机会分析。

策略分析：急性脊髓损伤市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球急性脊髓损伤市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球急性脊髓损伤市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球急性脊髓损伤市场
    • 完全性脊髓损伤
    • 不完全性脊髓损伤
  • 按最终用途分類的全球急性脊髓损伤市场
    • 医院
    • 创伤中心

第四章 2018-2030年区域市场趋势及预测分析

  • 全球急性脊髓损伤市场（按地区）
  • 北美急性脊髓损伤市场
  • 欧洲急性脊髓损伤市场
  • 亚太地区急性脊髓损伤市场
  • 其他地区急性脊髓损伤市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球急性脊髓损伤市场成长机会
    • 全球急性脊髓损伤市场成长机会（依最终用途）
    • 全球急性脊髓损伤市场成长机会（按地区）
  • 全球急性脊髓损伤市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球急性脊髓损伤市场的产能
    • 全球急性脊髓损伤市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Novartis
  • Tenax Therapeutics
  • Accure Pharma
  • Acorda Therapeutics
  • Asterias Biotherapeutics
  • ReNetX Bio
  • BioArctic
  • BioTime
  • InVivo Therapeutics
  • Kringle Pharma
简介目录

Acute Spinal Cord Injury Trends and Forecast

The future of the global acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets. The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.

A more than 150-page report is developed to help in your business decisions.

Acute Spinal Cord Injury by Segment

The study includes a forecast for the global acute spinal cord injury by type, end use, and region.

Acute Spinal Cord Injury Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Complete Spinal Cord Injury
  • Incomplete Spinal Cord Injury

Acute Spinal Cord Injury Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Trauma Centers

Acute Spinal Cord Injury Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Acute Spinal Cord Injury Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acute spinal cord injury companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acute spinal cord injury companies profiled in this report include-

  • Novartis
  • Tenax Therapeutics
  • Accure Pharma
  • Acorda Therapeutics
  • Asterias Biotherapeutics
  • Renetx Bio
  • Bioarctic
  • Biotime
  • Invivo Therapeutics
  • Kringle Pharma

Acute Spinal Cord Injury Market Insights

Lucintel forecasts that incomplete spinal cord injury (ISCI) will remain the larger segment over the forecast period due to increasing incidence of spinal cord injuries and growing awareness towards treatment of spinal cord injuries.

Within this market, hospital is expected to remain the larger segment due to growing number of inpatient rehabilitation programs at hospitals to deliver comprehensive services to help people.

North America will remain the largest region due to surge in aging population, well-developed healthcare system, and increasing adoption of advanced technologies in the region.

Features of the Global Acute Spinal Cord Injury Market

Market Size Estimates: Acute spinal cord injury market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acute spinal cord injury market size by type, end use, and region in terms of value ($B).

Regional Analysis: Acute spinal cord injury market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the acute spinal cord injury market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acute spinal cord injury market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the acute spinal cord injury market size?

Answer: The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030.

Q.2 What is the growth forecast for acute spinal cord injury market?

Answer: The global acute spinal cord injury market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the acute spinal cord injury market?

Answer: The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.

Q4. What are the major segments for acute spinal cord injury market?

Answer: The future of the acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets.

Q5. Who are the key acute spinal cord injury market companies?

Answer: Some of the key acute spinal cord injury companies are as follows:

  • Novartis
  • Tenax Therapeutics
  • Accure Pharma
  • Acorda Therapeutics
  • Asterias Biotherapeutics
  • Renetx Bio
  • Bioarctic
  • Biotime
  • Invivo Therapeutics
  • Kringle Pharma

Q6. Which acute spinal cord injury market segment will be the largest in future?

Answer: Lucintel forecasts that incomplete spinal cord injury (ISCI) will remain the larger segment over the forecast period due to increasing incidence of spinal cord injuries and growing awareness towards treatment of spinal cord injuries.

Q7. In acute spinal cord injury market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to surge in aging population, well-developed healthcare system, and increasing adoption of advanced technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the acute spinal cord injury market by type (complete spinal cord injury and incomplete spinal cord injury), end use (hospitals and trauma centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acute Spinal Cord Injury Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Acute Spinal Cord Injury Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Acute Spinal Cord Injury Market by Type
    • 3.3.1: Complete Spinal Cord Injury
    • 3.3.2: Incomplete Spinal Cord Injury
  • 3.4: Global Acute Spinal Cord Injury Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Trauma Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Acute Spinal Cord Injury Market by Region
  • 4.2: North American Acute Spinal Cord Injury Market
    • 4.2.2: North American Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
  • 4.3: European Acute Spinal Cord Injury Market
    • 4.3.1: European Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
    • 4.3.2: European Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
  • 4.4: APAC Acute Spinal Cord Injury Market
    • 4.4.1: APAC Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
    • 4.4.2: APAC Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
  • 4.5: ROW Acute Spinal Cord Injury Market
    • 4.5.1: ROW Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
    • 4.5.2: ROW Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Acute Spinal Cord Injury Market by Type
    • 6.1.2: Growth Opportunities for the Global Acute Spinal Cord Injury Market by End Use
    • 6.1.3: Growth Opportunities for the Global Acute Spinal Cord Injury Market by Region
  • 6.2: Emerging Trends in the Global Acute Spinal Cord Injury Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Acute Spinal Cord Injury Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acute Spinal Cord Injury Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Novartis
  • 7.2: Tenax Therapeutics
  • 7.3: Accure Pharma
  • 7.4: Acorda Therapeutics
  • 7.5: Asterias Biotherapeutics
  • 7.6: ReNetX Bio
  • 7.7: BioArctic
  • 7.8: BioTime
  • 7.9: InVivo Therapeutics
  • 7.10: Kringle Pharma